Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
|
2. Transaction Date (MM/DD/YY)
|
2A. Deemed Execution Date, if any (MM/DD/YY)
|
3. Transaction Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
|
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock |
02/22/2021 |
|
S(
1
) |
|
161,887 (
2
) |
D |
$
159.1794 (
2
) |
19,245,278 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
54,409 (
4
) |
D |
$
160.3709 (
4
) |
19,190,869 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
30,808 (
5
) |
D |
$
160.9585 (
5
) |
19,160,061 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
250,501 (
6
) |
D |
$
162.3628 (
6
) |
18,909,560 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
366,471 (
7
) |
D |
$
163.2527 (
7
) |
18,543,089 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
189,200 (
8
) |
D |
$
164.1346 (
8
) |
18,353,889 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
165,578 (
9
) |
D |
$
165.4687 (
9
) |
18,188,311 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
351,578 (
10
) |
D |
$
166.2968 (
10
) |
17,837,101 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
122,715 (
11
) |
D |
$
167.1006 (
11
) |
17,714,386 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
58,377 (
12
) |
D |
$
168.1117 (
12
) |
17,656,009 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
54,274 (
13
) |
D |
$
169.1401 (
13
) |
17,601,735 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/22/2021 |
|
S(
1
) |
|
30,968 (
14
) |
D |
$
170.0278 (
14
) |
17,570,797 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
9,985 (
15
) |
D |
$
136.482 (
15
) |
17,560,812 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
122,142 (
16
) |
D |
$
137.2906 (
16
) |
17,438,670 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
46,222 (
17
) |
D |
$
138.5585 (
17
) |
17,392,448 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
56,435 (
18
) |
D |
$
139.6447 (
18
) |
17,336,013 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
102,852 (
19
) |
D |
$
140.236 (
19
) |
17,233,161 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
70,631 (
20
) |
D |
$
141.4573 (
20
) |
17,162,530 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
117,011 (
21
) |
D |
$
142.7605 (
21
) |
17,045,519 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
397,126 (
22
) |
D |
$
143.5744 (
22
) |
16,648,393 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
405,551 (
23
) |
D |
$
144.5529 (
23
) |
16,242,842 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
357,316 (
24
) |
D |
$
145.4803 (
24
) |
15,885,526 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
307,795 (
25
) |
D |
$
146.6369 (
25
) |
15,577,731 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
292,483 (
26
) |
D |
$
147.5729 (
26
) |
15,285,248 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
268,688 (
27
) |
D |
$
148.521 (
27
) |
15,016,560 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
179,268 (
28
) |
D |
$
149.626 (
28
) |
14,837,292 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
190,710 (
29
) |
D |
$
150.5137 (
29
) |
14,646,582 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
02/23/2021 |
|
S(
1
) |
|
23,423 (
30
) |
D |
$
151.2851 (
30
) |
14,623,159 (
31
) |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
|
|
|
|
|
|
|
11,464,359 (
32
) |
I |
By Flagship VentureLabs IV LLC and Flagship Pioneering, Inc. (
32
) |
Common Stock |
|
|
|
|
|
|
|
2,101,703 |
D |
|
|